Literature DB >> 6291255

Calcium channel blockers.

P C Deedwania.   

Abstract

Calcium (Ca(++)) plays an essential role in many cardiovascular physiologic processes. Electrophysiologic properties of the sinus and atrioventricular nodes greatly depend on Ca(++) ion influx. Also, Ca(++) is the main link for excitation-contraction coupling of the myocardium. Ca(++) channel blockers are a group of heterogeneous compounds that block the ionic influx of Ca(++) into the myocardial and vascular smooth muscle cells. Because Ca(++) plays a central role, it is not surprising that Ca(++) channel blockers can produce profound alterations in cardiovascular functions. Recently several studies have shown these agents to be useful in the treatment of supraventricular tachyarrhythmia, variant angina, chronic stable angina and hypertrophic cardiomyopathy. In the future they may be found useful in preserving myocardium during cardiopulmonary bypass, in limiting infarct size and in the treatment of hypertension and congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6291255      PMCID: PMC1273979     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  50 in total

1.  Therapeutic implications of slow-channel blockade in cardiocirculatory disorders.

Authors:  G Ellrodt; C Y Chew; B N Singh
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

Review 2.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications.

Authors:  P H Stone; E M Antman; J E Muller; E Braunwald
Journal:  Ann Intern Med       Date:  1980-12       Impact factor: 25.391

3.  Efficacy of nifedipine in rest angina refractory to propranolol and nitrates in patients with obstructive coronary artery disease.

Authors:  J W Moses; J H Wertheimer; M M Bodenheimer; V S Banka; M Feldman; R H Helfant
Journal:  Ann Intern Med       Date:  1981-04       Impact factor: 25.391

4.  Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium.

Authors:  W G Nayler; R Ferrari; A Williams
Journal:  Am J Cardiol       Date:  1980-08       Impact factor: 2.778

5.  Treatment of variant angina with drugs: a survey of 11 cardiology institutes in Japan.

Authors:  E Kimura; H Kishida
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

6.  Improved exercise performance in persons with stable angina pectoris receiving diltiazem.

Authors:  K F Hossack; R A Bruce
Journal:  Am J Cardiol       Date:  1981-01       Impact factor: 2.778

7.  Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study.

Authors:  H L Waxman; R J Myerburg; R Appel; R J Sung
Journal:  Ann Intern Med       Date:  1981-01       Impact factor: 25.391

8.  Hemodynamic effects of nifedipine in congestive heart failure.

Authors:  S Matsumoto; T Ito; T Sada; M Takahashi; K M Su; A Ueda; F Okabe; M Sato; I Sekine; Y Ito
Journal:  Am J Cardiol       Date:  1980-09       Impact factor: 2.778

9.  Efficacy of diltiazem for control of symptoms of coronary arterial spasm.

Authors:  S J Rosenthal; R Ginsburg; I H Lamb; D S Baim; J S Schroeder
Journal:  Am J Cardiol       Date:  1980-12-01       Impact factor: 2.778

10.  Studies with isolated human coronary arteries. Some general observations, potential mediators of spasm, role of calcium antagonists.

Authors:  R Ginsburg; M R Bristow; D C Harrison; E B Stinson
Journal:  Chest       Date:  1980-07       Impact factor: 9.410

View more
  1 in total

1.  Verapamil enhances the antitumoral efficacy of oncolytic adenoviruses.

Authors:  Alena Gros; Cristina Puig; Sonia Guedan; Juan José Rojas; Ramon Alemany; Manel Cascallo
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.